New study explores blood, skin, and nasal swabs to spot Parkinson's early

NCT ID NCT07480187

Ongoing Diagnosis Sponsor: Azienda Ospedaliera di Perugia Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is looking for better ways to diagnose Parkinson's disease using samples that are easy to collect, like blood, skin, and nasal swabs. Researchers will compare these samples from 340 people, including those with Parkinson's, Alzheimer's, and healthy volunteers. The goal is to find biological markers that could lead to a simpler, more accurate diagnosis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simple, non-invasive test for Parkinson's disease, enabling earlier diagnosis and better clinical trials.
What could go wrong: This is an observational study, not a treatment trial. The biomarkers may not prove accurate enough for widespread use, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Parkinson disease subjective cognitive decline synucleinopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER DISEASE PARKINSON DISEASE SYNUCLEINOPATHY

Contacts and locations

Locations

Azienda Ospedaliera di Perugia

Perugia, 06129, Italy
Centro Neurolesi Bonino Pulejo

Messina, Messina, 98124, Italy
Istituto Neurologico Carlo Besta

Milan, Milano, 20133, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.